Hostname: page-component-6bf8c574d5-qdpjg Total loading time: 0 Render date: 2025-02-16T22:14:13.597Z Has data issue: false hasContentIssue false
  • English
  • Français

Attenuated glucose-stimulated insulin secretion during an acute IGF-1 LR3 infusion into fetal sheep does not persist in isolated islets

Published online by Cambridge University Press:  28 April 2023

Alicia White Open the ORCID record for Alicia White [Opens in a new window] ,
Jane Stremming ,
Laura D. Brown  and
Paul J. Rozance
Alicia White*
Affiliation:
Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Jane Stremming
Affiliation:
Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Laura D. Brown
Affiliation:
Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Paul J. Rozance
Affiliation:
Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
*
Corresponding Author: Alicia White, Perinatal Research Center, Department of Pediatrics, University of Colorado Anschutz Medical Campus, 13243 E 23rd Avenue, MS F441, Aurora, CO 80045, USA. Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Insulin-like growth factor-1 (IGF-1) is a critical fetal growth hormone that has been proposed as a therapy for intrauterine growth restriction. We previously demonstrated that a 1-week IGF-1 LR3 infusion into fetal sheep reduces in vivo and in vitro insulin secretion suggesting an intrinsic islet defect. Our objective herein was to determine whether this intrinsic islet defect was related to chronicity of exposure. We therefore tested the effects of a 90-min IGF-1 LR3 infusion on fetal glucose-stimulated insulin secretion (GSIS) and insulin secretion from isolated fetal islets. We first infused late gestation fetal sheep (n = 10) with either IGF-1 LR3 (IGF-1) or vehicle control (CON) and measured basal insulin secretion and in vivo GSIS utilizing a hyperglycemic clamp. We then isolated fetal islets immediately following a 90-min IGF-1 or CON in vivo infusion and exposed them to glucose or potassium chloride to measure in vitro insulin secretion (IGF-1, n = 6; CON, n = 6). Fetal plasma insulin concentrations decreased with IGF-1 LR3 infusion (P < 0.05), and insulin concentrations during the hyperglycemic clamp were 66% lower with IGF-1 LR3 infusion compared to CON (P < 0.0001). Insulin secretion in isolated fetal islets was not different based on infusion at the time of islet collection. Therefore, we speculate that while acute IGF-1 LR3 infusion may directly suppress insulin secretion, the fetal β-cell in vitro retains the ability to recover GSIS. This may have important implications when considering the long-term effects of treatment modalities for fetal growth restriction.

Keywords

fetusinsulin-like growth factorβ-cellglucose-stimulated insulin secretion
Type
Original Article
Information
Journal of Developmental Origins of Health and Disease , Volume 14 , Issue 3 , June 2023 , pp. 353 - 361
Check for updates
Copyright
© The Author(s), 2023. Published by Cambridge University Press in association with International Society for Developmental Origins of Health and Disease

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Fowden, AL. The role of insulin in fetal growth. Early Hum Dev. 1992; 29, 177–181.CrossRefGoogle ScholarPubMed
Fowden, AL. The insulin-like growth factors and feto-placental growth. Placenta. 2003; 24, 803–812.CrossRefGoogle ScholarPubMed
Lassarre, C, Hardouin, S, Daffos, F, et al. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res. 1991; 29, 219–225.CrossRefGoogle ScholarPubMed
Christou, H, Connors, JM, Ziotopoulou, M, et al. Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab. 2001; 86, 935–938.CrossRefGoogle ScholarPubMed
Ostlund, E, Bang, P, Hagenäs, L, Fried, G. Insulin-like growth factor I in fetal serum obtained by cordocentesis is correlated with intrauterine growth retardation. Hum Reprod. 1997; 12, 840–844.CrossRefGoogle ScholarPubMed
Brown, LD, Palmer, C, Teynor, L, et al. Fetal Sex Does Not Impact Placental Blood Flow or Placental Amino Acid Transfer in Late Gestation Pregnant Sheep With or Without Placental Insufficiency. Reprod Sci. 2021. https://doi.org/10.1007/s43032-021-00750-9.Google ScholarPubMed
Ong, K, Kratzsch, J, Kiess, W, et al. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Clin Endocrinol Metab. 2000; 85, 4266–4269.Google Scholar
Jensen, EC, Harding, JE, Bauer, MK, Gluckman, PD. Metabolic effects of IGF-I in the growth retarded fetal sheep. J Endocrinol. 1999; 161, 485–494.CrossRefGoogle ScholarPubMed
Wali, JA, de Boo, HA, Derraik, JG, et al. Weekly intra-amniotic IGF-1 treatment increases growth of growth-restricted ovine fetuses and up-regulates placental amino acid transporters. PLoS One. 2012; 7, e37899.CrossRefGoogle ScholarPubMed
Eremia, SC, de Boo, HA, Bloomfield, FH, Oliver, MH, Harding, JE. Fetal and amniotic insulin-like growth factor-I supplements improve growth rate in intrauterine growth restriction fetal sheep. Endocrinology. 2007; 148, 2963–2972.CrossRefGoogle ScholarPubMed
Han, VK, Lund, PK, Lee, DC, D’Ercole, AJ. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. J Clin Endocrinol Metab. 1988; 66, 422–429.CrossRefGoogle ScholarPubMed
Agrogiannis, GD, Sifakis, S, Patsouris, ES, Konstantinidou, AE. Insulin-like growth factors in embryonic and fetal growth and skeletal development (Review). Mol Med Rep. 2014; 10, 579–584.CrossRefGoogle ScholarPubMed
Lok, F, Owens, JA, Mundy, L, Robinson, JS, Owens, PC. Insulin-like growth factor I promotes growth selectively in fetal sheep in late gestation. Am J Physiol. 1996; 270, R1148–R1155.Google ScholarPubMed
White, A, Louey, S, Chang, EI, et al. A 1 week IGF-1 infusion decreases arterial insulin concentrations but increases pancreatic insulin content and islet vascularity in fetal sheep. Physiol Rep. 2018; 6, e13840.CrossRefGoogle ScholarPubMed
Stremming, J, Heard, S, White, A, et al. IGF-1 infusion to fetal sheep increases organ growth but not by stimulating nutrient transfer to the fetus. Am J Physiol Endocrinol Metab. 2021; 320, E527–E538.CrossRefGoogle Scholar
Rotwein, P. Diversification of the insulin-like growth factor 1 gene in mammals. PLoS One. 2017; 12, e0189642.CrossRefGoogle ScholarPubMed
Francis, GL, Ross, M, Ballard, FJ, et al. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. J Mol Endocrinol. 1992; 8, 213–223.CrossRefGoogle ScholarPubMed
Mabley, JG, Belin, V, John, N, Green, IC. Insulin-like growth factor I reverses interleukin-1beta inhibition of insulin secretion, induction of nitric oxide synthase and cytokine-mediated apoptosis in rat islets of Langerhans. FEBS Lett. 1997; 417, 235–238.CrossRefGoogle ScholarPubMed
Giannoukakis, N, Mi, Z, Rudert, WA, et al. Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I. Gene Ther. 2000; 7, 2015–2022.CrossRefGoogle ScholarPubMed
Robertson, K, Lu, Y, De Jesus, K, et al. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes. Am J Physiol Endocrinol Metab. 2008; 294, E928–E938.CrossRefGoogle ScholarPubMed
Pørksen, N, Hussain, MA, Bianda, TL, et al. IGF-I inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-I infusion rates. Am J Physiol. 1997; 272, E352–E358.Google ScholarPubMed
Leahy, JL, Vandekerkhove, KM. Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology. 1990; 126, 1593–1598.CrossRefGoogle ScholarPubMed
White, A, Stremming, J, Boehmer, BH, et al. Reduced glucose-stimulated insulin secretion following a 1-wk IGF-1 infusion in late gestation fetal sheep is due to an intrinsic islet defect. Am J Physiol Endocrinol Metab. 2021; 320, E1138–E1147.CrossRefGoogle Scholar
Rozance, PJ, Limesand, SW, Hay, WW Jr. Decreased nutrient-stimulated insulin secretion in chronically hypoglycemic late-gestation fetal sheep is due to an intrinsic islet defect. Am J Physiol Endocrinol Metab. 2006; 291, E404–E411.CrossRefGoogle Scholar
Rozance, PJ, Limesand, SW, Zerbe, GO, Hay, WW Jr. Chronic fetal hypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic beta-cells. Am J Physiol Endocrinol Metab. 2007; 292, E1256–1264.CrossRefGoogle ScholarPubMed
Percie du Sert, N, Hurst, V, Ahluwalia, A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Physiol. 2020. https://doi.org/10.1113/jp280389.CrossRefGoogle ScholarPubMed
Hay, WW Jr, Sparks, JW, Quissell, BJ, Battaglia, FC, Meschia, G. Simultaneous measurements of umbilical uptake, fetal utilization rate, and fetal turnover rate of glucose. Am J Physiol. 1981; 240, E662–E668.Google ScholarPubMed
Hay, WW Jr., Sparks, JW, Battaglia, FC, Meschia, G. Maternal-fetal glucose exchange: necessity of a three-pool model. Am J Physiol. 1984; 246, E528–E534.Google ScholarPubMed
DiGiacomo, JE, Hay, WW Jr. Fetal glucose metabolism and oxygen consumption during sustained hypoglycemia. Metabolism. 1990; 39, 193–202.CrossRefGoogle ScholarPubMed
Culpepper, C, Wesolowski, SR, Benjamin, J, et al. Chronic anemic hypoxemia increases plasma glucagon and hepatic PCK1 mRNA in late-gestation fetal sheep. Am J Physiol Regul Integr Comp Physiol. 2016; 311, R200–R208.CrossRefGoogle ScholarPubMed
Boehmer, BH, Brown, LD, Wesolowski, SR, Hay, WW, Rozance, PJ. A Chronic Fetal Leucine Infusion Potentiates Fetal Insulin Secretion and Increases Pancreatic Islet Size, Vascularity, and β Cells in Late-Gestation Sheep. J Nutr. 2020; 150, 2061–2069.CrossRefGoogle ScholarPubMed
Sundgren, NC, Giraud, GD, Schultz, JM, et al. Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal sheep cardiomyocytes. Am J Physiol Regul Integr Comp Physiol. 2003; 285, R1481–R1489.CrossRefGoogle ScholarPubMed
Boehmer, BH, Baker Ii, PR, Brown, LD, Wesolowski, SR, Rozance, PJ. Leucine acutely potentiates glucose-stimulated insulin secretion in fetal sheep. J Endocrinol. 2020. https://doi.org/10.1530/joe-20-0243.CrossRefGoogle ScholarPubMed
Andrews, SE, Brown, LD, Thorn, SR, et al. Increased adrenergic signaling is responsible for decreased glucose-stimulated insulin secretion in the chronically hyperinsulinemic ovine fetus. Endocrinology. 2015; 156, 367–376.CrossRefGoogle ScholarPubMed
Gadhia, MM, Maliszewski, AM, O’Meara, MC, et al. Increased amino acid supply potentiates glucose-stimulated insulin secretion but does not increase beta-cell mass in fetal sheep. Am J Physiol Endocrinol Metab. 2013; 304, E352–362.CrossRefGoogle Scholar
Green, AS, Macko, AR, Rozance, PJ, et al. Characterization of glucose-insulin responsiveness and impact of fetal number and sex difference on insulin response in the sheep fetus. Am J Physiol Endocrinol Metab. 2011; 300, E817–823.CrossRefGoogle ScholarPubMed
Limesand, SW, Rozance, PJ, Zerbe, GO, Hutton, JC, Hay, WW Jr. Attenuated insulin release and storage in fetal sheep pancreatic islets with intrauterine growth restriction. Endocrinology. 2006; 147, 1488–1497.CrossRefGoogle ScholarPubMed
Benjamin, JS, Culpepper, CB, Brown, LD, et al. Chronic anemic hypoxemia attenuates glucose-stimulated insulin secretion in fetal sheep. Am J Physiol Regul Integr Comp Physiol. 2017; 312, R492–R500.CrossRefGoogle ScholarPubMed
Oliver, MH, Harding, JE, Breier, BH, Gluckman, PD. Fetal insulin-like growth factor (IGF)-I and IGF-II are regulated differently by glucose or insulin in the sheep fetus. Reprod Fertil Dev. 1996; 8, 167–172.CrossRefGoogle ScholarPubMed
Liechty, EA, Boyle, DW, Moorehead, H, et al. Effects of circulating IGF-I on glucose and amino acid kinetics in the ovine fetus. Am J Physiol. 1996; 271, E177–E185.Google ScholarPubMed
Brown, LD, Davis, M, Wai, S, et al. Chronically increased amino acids improve insulin secretion, pancreatic vascularity, and islet size in growth-restricted fetal sheep. Endocrinology. 2016; 157, 3788–3799.CrossRefGoogle ScholarPubMed
Dahri, S, Snoeck, A, Reusens-Billen, B, Remacle, C, Hoet, JJ. Islet function in offspring of mothers on low-protein diet during gestation. Diabetes. 1991; 40(Suppl. 2), 115–120.CrossRefGoogle ScholarPubMed
Liechty, EA, Boyle, DW, Moorehead, H, et al. Glucose and amino acid kinetic response to graded infusion of rhIGF-I in the late gestation ovine fetus. Am J Physiol. 1999; 277, E537–543.Google ScholarPubMed
Fowden, AL, Li, J, Forhead, AJ. Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance? Proc Nutr Soc. 1998; 57, 113–122.CrossRefGoogle ScholarPubMed
Kawai, K, Suzuki, S, Takano, K, et al. Effects of insulin-like growth factor-I on insulin and glucagon release from isolated perfused rat pancreas. Endocrinol Jpn. 1990; 37, 867–874.CrossRefGoogle ScholarPubMed